Nadav Kidron - Net Worth and Insider Trading
Nadav Kidron Net Worth
The estimated net worth of Nadav Kidron is at least $3 Million dollars as of 2024-04-30. Nadav Kidron is the President and CEO of Oramed Pharmaceuticals Inc and owns about 1,179,098 shares of Oramed Pharmaceuticals Inc (ORMP) stock worth over $3 Million. Details can be seen in Nadav Kidron's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nadav Kidron has not made any transactions after 2023-03-16 and currently still holds the listed stock(s).
Transaction Summary of Nadav Kidron
Nadav Kidron Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nadav Kidron owns 1 companies in total, including Oramed Pharmaceuticals Inc (ORMP) .
Click here to see the complete history of Nadav Kidron’s form 4 insider trades.
Insider Ownership Summary of Nadav Kidron
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ORMP | Oramed Pharmaceuticals Inc | 2023-03-16 | director & 10 percent owner |
Nadav Kidron Latest Holdings Summary
Nadav Kidron currently owns a total of 1 stock. Nadav Kidron owns 1,179,098 shares of Oramed Pharmaceuticals Inc (ORMP) as of March 16, 2023, with a value of $3 Million.
Latest Holdings of Nadav Kidron
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ORMP | Oramed Pharmaceuticals Inc | 2023-03-16 | 1,179,098 | 2.32 | 2,735,507 |
Holding Weightings of Nadav Kidron
Nadav Kidron Form 4 Trading Tracker
According to the SEC Form 4 filings, Nadav Kidron has made a total of 4 transactions in Oramed Pharmaceuticals Inc (ORMP) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Oramed Pharmaceuticals Inc is the acquisition of 26,000 shares on March 16, 2023, which cost Nadav Kidron around $53,040.
Insider Trading History of Nadav Kidron
- 1
Nadav Kidron Trading Performance
GuruFocus tracks the stock performance after each of Nadav Kidron's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nadav Kidron is 31.7%. GuruFocus also compares Nadav Kidron's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nadav Kidron within 3 months outperforms 5 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nadav Kidron's insider trading performs compared to the benchmark.
Performance of Nadav Kidron
Average Return
16.21%
Outperforming Transactions
83%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.22 | 31.7 | 15.85 | 16.21 | 3.04 | 7.43 |
| Relative Return to S&P 500(%) | 18.04 | 27.12 | 13.02 | 2.72 | -5.85 | -4.16 |
Nadav Kidron Ownership Network
Ownership Network List of Nadav Kidron
Ownership Network Relation of Nadav Kidron
Nadav Kidron Owned Company Details
What does Oramed Pharmaceuticals Inc do?
Who are the key executives at Oramed Pharmaceuticals Inc?
Nadav Kidron is the director & 10 percent owner of Oramed Pharmaceuticals Inc. Other key executives at Oramed Pharmaceuticals Inc include Chief Commercial Officer Michael Rabinowitz , Chief Financial Officer David Silberman , and Chief Legal Officer Netanel Derovan .
Oramed Pharmaceuticals Inc (ORMP) Insider Trades Summary
Over the past 18 months, Nadav Kidron made 2 insider transaction in Oramed Pharmaceuticals Inc (ORMP) with a net purchase of 126,000. Other recent insider transactions involving Oramed Pharmaceuticals Inc (ORMP) include a net sale of 100,000 shares made by Miriam Kidron , a net purchase of 70,000 shares made by Yadin Rozov , and a net sale of 13,325 shares made by Michael Rabinowitz .
In summary, during the past 3 months, insiders sold 0 shares of Oramed Pharmaceuticals Inc (ORMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 113,325 shares of Oramed Pharmaceuticals Inc (ORMP) were sold and 196,000 shares were bought by its insiders, resulting in a net purchase of 82,675 shares.
Oramed Pharmaceuticals Inc (ORMP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oramed Pharmaceuticals Inc Insider Transactions
Nadav Kidron Mailing Address
Above is the net worth, insider trading, and ownership report for Nadav Kidron. You might contact Nadav Kidron via mailing address: 142 W. 57th St., New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
